MIT spinout Iterative Scopes has now raised $43.5m altogether from investors including Eli Lilly and Johnson & Johnson.
Iterative Scopes, a US-based precision medicine company focused on gastroenterology that is based on research at Massachusetts Institute of Technology (MIT), has completed a $30m series A round.
The round was led by Obvious Ventures, with additional commitments from pharmaceutical firms Eli Lilly and Johnson & Johnson, the latter investing through corporate venturing arm Johnson & Johnson Innovation – JJDC.
Breyer Capital, Seae Ventures and private investors also took part.
Founded in 2017, Iterative Scopes is working…
